SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'UHB'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DMA_A_NCAA700_0 (EXOTOXIN A)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	4 / 7	HIS A 415 GLY A 416 TYR A 449 TYR A 460	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 (-3.4A)	0.31A	1dmaA-5dsyA: 5.8	1dmaA-5dsyA: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DMA_A_NCAA700_0 (EXOTOXIN A)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	4 / 7	HIS A 415 GLY A 416 TYR A 460 GLU A 545	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.4A) UHB A1001 (-3.5A)	0.52A	1dmaA-5dsyA: 5.8	1dmaA-5dsyA: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DMA_B_NCAB700_0 (EXOTOXIN A)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	6 / 6	HIS A 415 GLY A 416 TYR A 449 ALA A 451 TYR A 460 GLU A 545	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 ( 4.1A) UHB A1001 (-3.4A) UHB A1001 (-3.5A)	0.52A	1dmaB-5dsyA: 5.1	1dmaB-5dsyA: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ERR_A_RALA600_2 (ESTROGEN RECEPTOR)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	4 / 6	LEU A 412 HIS A 415 LEU A 391 LEU A 359	None UHB A1001 (-3.7A) None None	0.88A	1errA-5dsyA: undetectable	1errA-5dsyA: 22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XAT_A_CLMA301_0 (XENOBIOTIC ACETYLTRANSFERASE)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	3 / 3	GLY A 416 TYR A 460 SER A 457	UHB A1001 (-3.9A) UHB A1001 (-3.4A) UHB A1001 (-2.5A)	0.75A	2xatA-5dsyA: undetectable	2xatA-5dsyA: 20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_A_NCAA1163_0 (TANKYRASE-2)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	6 / 8	HIS A 415 GLY A 416 TYR A 449 ALA A 451 SER A 457 TYR A 460	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 ( 4.1A) UHB A1001 (-2.5A) UHB A1001 (-3.4A)	0.42A	3u9hA-5dsyA: 18.6	3u9hA-5dsyA: 29.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_A_NCAA1163_0 (TANKYRASE-2)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	6 / 8	HIS A 415 GLY A 416 TYR A 449 LYS A 456 SER A 457 TYR A 460	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 ( 4.6A) UHB A1001 (-2.5A) UHB A1001 (-3.4A)	0.96A	3u9hA-5dsyA: 18.6	3u9hA-5dsyA: 29.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_A_NCAA1163_0 (TANKYRASE-2)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	6 / 8	HIS A 415 GLY A 416 TYR A 449 SER A 457 TYR A 460 GLU A 545	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 (-2.5A) UHB A1001 (-3.4A) UHB A1001 (-3.5A)	0.81A	3u9hA-5dsyA: 18.6	3u9hA-5dsyA: 29.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_B_NCAB1164_0 (TANKYRASE-2)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	7 / 8	HIS A 415 GLY A 416 TYR A 449 ALA A 451 SER A 457 TYR A 460 GLU A 545	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 ( 4.1A) UHB A1001 (-2.5A) UHB A1001 (-3.4A) UHB A1001 (-3.5A)	0.81A	3u9hB-5dsyA: 18.6	3u9hB-5dsyA: 29.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9H_B_NCAB1164_0 (TANKYRASE-2)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	6 / 8	HIS A 415 GLY A 416 TYR A 449 LYS A 456 SER A 457 TYR A 460	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 ( 4.6A) UHB A1001 (-2.5A) UHB A1001 (-3.4A)	1.00A	3u9hB-5dsyA: 18.6	3u9hB-5dsyA: 29.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AE1_A_NCAA1536_0 (DIPHTHERIA TOXIN)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	5 / 6	HIS A 415 GLY A 416 TYR A 449 TYR A 460 GLU A 545	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 (-3.4A) UHB A1001 (-3.5A)	0.69A	4ae1A-5dsyA: 5.4	4ae1A-5dsyA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AE1_B_NCAB1536_0 (DIPHTHERIA TOXIN)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	5 / 5	HIS A 415 GLY A 416 TYR A 449 TYR A 460 GLU A 545	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 (-3.4A) UHB A1001 (-3.5A)	0.75A	4ae1B-5dsyA: 5.7	4ae1B-5dsyA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BJC_A_RPBA2162_1 (TANKYRASE-2)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	7 / 8	HIS A 415 GLY A 416 TYR A 449 ALA A 451 LYS A 456 SER A 457 GLU A 545	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 ( 4.1A) UHB A1001 ( 4.6A) UHB A1001 (-2.5A) UHB A1001 (-3.5A)	1.29A	4bjcA-5dsyA: 18.4	4bjcA-5dsyA: 29.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BJC_A_RPBA2162_1 (TANKYRASE-2)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	7 / 8	HIS A 415 GLY A 416 TYR A 449 ALA A 451 SER A 457 TYR A 460 GLU A 545	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 ( 4.1A) UHB A1001 (-2.5A) UHB A1001 (-3.4A) UHB A1001 (-3.5A)	0.78A	4bjcA-5dsyA: 18.4	4bjcA-5dsyA: 29.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_A_NCAA1201_0 (TANKYRASE-2)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	7 / 7	HIS A 415 GLY A 416 TYR A 449 ALA A 451 SER A 457 TYR A 460 GLU A 545	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 ( 4.1A) UHB A1001 (-2.5A) UHB A1001 (-3.4A) UHB A1001 (-3.5A)	0.61A	4hyfA-5dsyA: 19.5	4hyfA-5dsyA: 29.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_B_NCAB1201_0 (TANKYRASE-2)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	8 / 8	HIS A 415 GLY A 416 TYR A 449 ALA A 451 LYS A 456 SER A 457 TYR A 460 GLU A 545	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 ( 4.1A) UHB A1001 ( 4.6A) UHB A1001 (-2.5A) UHB A1001 (-3.4A) UHB A1001 (-3.5A)	0.93A	4hyfB-5dsyA: 19.7	4hyfB-5dsyA: 29.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYF_C_NCAC1201_0 (TANKYRASE-2)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	8 / 8	HIS A 415 GLY A 416 TYR A 449 ALA A 451 LYS A 456 SER A 457 TYR A 460 GLU A 545	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 (-3.8A) UHB A1001 ( 4.1A) UHB A1001 ( 4.6A) UHB A1001 (-2.5A) UHB A1001 (-3.4A) UHB A1001 (-3.5A)	0.57A	4hyfC-5dsyA: 19.6	4hyfC-5dsyA: 29.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J26_A_ESTA600_1 (ESTROGEN RECEPTOR BETA)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	5 / 12	LEU A 471 MET A 556 LEU A 356 GLY A 429 LEU A 430	None None None None UHB A1001 ( 4.7A)	1.29A	4j26A-5dsyA: undetectable	4j26A-5dsyA: 23.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RV6_A_RPBA1103_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	9 / 11	HIS A 415 GLY A 416 TYR A 442 TYR A 449 ALA A 451 LYS A 456 SER A 457 TYR A 460 GLU A 545	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 ( 4.7A) UHB A1001 (-3.8A) UHB A1001 ( 4.1A) UHB A1001 ( 4.6A) UHB A1001 (-2.5A) UHB A1001 (-3.4A) UHB A1001 (-3.5A)	0.57A	4rv6A-5dsyA: 35.2	4rv6A-5dsyA: 40.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RV6_B_RPBB1103_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	9 / 11	HIS A 415 GLY A 416 TYR A 442 TYR A 449 ALA A 451 LYS A 456 SER A 457 TYR A 460 GLU A 545	UHB A1001 (-3.7A) UHB A1001 (-3.9A) UHB A1001 ( 4.7A) UHB A1001 (-3.8A) UHB A1001 ( 4.1A) UHB A1001 ( 4.6A) UHB A1001 (-2.5A) UHB A1001 (-3.4A) UHB A1001 (-3.5A)	0.57A	4rv6B-5dsyA: 36.1	4rv6B-5dsyA: 40.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HA9_B_TP0B406_1 (POLY [ADP-RIBOSE] POLYMERASE 1)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	7 / 9	HIS A 415 SER A 417 ASN A 421 ILE A 425 TYR A 449 SER A 457 TYR A 460	UHB A1001 (-3.7A) UHB A1001 (-2.5A) UHB A1001 (-3.7A) UHB A1001 (-4.6A) UHB A1001 (-3.8A) UHB A1001 (-2.5A) UHB A1001 (-3.4A)	0.53A	5ha9B-5dsyA: 32.8	5ha9B-5dsyA: 40.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y2T_A_8LXA501_0 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	5dsy	POLY [ADP-RIBOSE] POLYMERASE 2 (Homo sapiens)	5 / 12	PHE A 444 GLY A 445 TYR A 460 ILE A 432 LEU A 541	None None UHB A1001 (-3.4A) None None	1.01A	5y2tA-5dsyA: undetectable	5y2tA-5dsyA: undetectable

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DMA_A_NCAA700_0","EXOTOXIN A","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",4,"HIS A 415;GLY A 416;TYR A 449;TYR A 460","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 (-3.4A)","0.31A","1dmaA-5dsyA:5.8",null],["1DMA_A_NCAA700_0","EXOTOXIN A","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",4,"HIS A 415;GLY A 416;TYR A 460;GLU A 545","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.4A);UHB A1001 (-3.5A)","0.52A","1dmaA-5dsyA:5.8","1dmaA-5dsyA:21.01"],["1DMA_B_NCAB700_0","EXOTOXIN A","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",6,"HIS A 415;GLY A 416;TYR A 449;ALA A 451;TYR A 460;GLU A 545","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 ( 4.1A);UHB A1001 (-3.4A);UHB A1001 (-3.5A)","0.52A","1dmaB-5dsyA:5.1","1dmaA-5dsyA:21.01"],["1ERR_A_RALA600_2","ESTROGEN RECEPTOR","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",4,"LEU A 412;HIS A 415;LEU A 391;LEU A 359","None;UHB A1001 (-3.7A);None;None","0.88A","1errA-5dsyA:undetectable","1dmaB-5dsyA:21.01"],["2XAT_A_CLMA301_0","XENOBIOTIC ACETYLTRANSFERASE","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",3,"GLY A 416;TYR A 460;SER A 457","UHB A1001 (-3.9A);UHB A1001 (-3.4A);UHB A1001 (-2.5A)","0.75A","2xatA-5dsyA:undetectable","1errA-5dsyA:22.03"],["3U9H_A_NCAA1163_0","TANKYRASE-2","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",6,"HIS A 415;GLY A 416;TYR A 449;ALA A 451;SER A 457;TYR A 460","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 ( 4.1A);UHB A1001 (-2.5A);UHB A1001 (-3.4A)","0.42A","3u9hA-5dsyA:18.6","2xatA-5dsyA:20.96"],["3U9H_A_NCAA1163_0","TANKYRASE-2","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",6,"HIS A 415;GLY A 416;TYR A 449;LYS A 456;SER A 457;TYR A 460","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 ( 4.6A);UHB A1001 (-2.5A);UHB A1001 (-3.4A)","0.96A","3u9hA-5dsyA:18.6","3u9hA-5dsyA:29.11"],["3U9H_A_NCAA1163_0","TANKYRASE-2","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",6,"HIS A 415;GLY A 416;TYR A 449;SER A 457;TYR A 460;GLU A 545","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 (-2.5A);UHB A1001 (-3.4A);UHB A1001 (-3.5A)","0.81A","3u9hA-5dsyA:18.6","3u9hA-5dsyA:29.11"],["3U9H_B_NCAB1164_0","TANKYRASE-2","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",7,"HIS A 415;GLY A 416;TYR A 449;ALA A 451;SER A 457;TYR A 460;GLU A 545","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 ( 4.1A);UHB A1001 (-2.5A);UHB A1001 (-3.4A);UHB A1001 (-3.5A)","0.81A","3u9hB-5dsyA:18.6","3u9hA-5dsyA:29.11"],["3U9H_B_NCAB1164_0","TANKYRASE-2","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",6,"HIS A 415;GLY A 416;TYR A 449;LYS A 456;SER A 457;TYR A 460","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 ( 4.6A);UHB A1001 (-2.5A);UHB A1001 (-3.4A)","1.00A","3u9hB-5dsyA:18.6","3u9hB-5dsyA:29.11"],["4AE1_A_NCAA1536_0","DIPHTHERIA TOXIN","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",5,"HIS A 415;GLY A 416;TYR A 449;TYR A 460;GLU A 545","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 (-3.4A);UHB A1001 (-3.5A)","0.69A","4ae1A-5dsyA:5.4","3u9hB-5dsyA:29.11"],["4AE1_B_NCAB1536_0","DIPHTHERIA TOXIN","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",5,"HIS A 415;GLY A 416;TYR A 449;TYR A 460;GLU A 545","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 (-3.4A);UHB A1001 (-3.5A)","0.75A","4ae1B-5dsyA:5.7","4ae1A-5dsyA:undetectable"],["4BJC_A_RPBA2162_1","TANKYRASE-2","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",7,"HIS A 415;GLY A 416;TYR A 449;ALA A 451;LYS A 456;SER A 457;GLU A 545","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 ( 4.1A);UHB A1001 ( 4.6A);UHB A1001 (-2.5A);UHB A1001 (-3.5A)","1.29A","4bjcA-5dsyA:18.4","4ae1B-5dsyA:18.98"],["4BJC_A_RPBA2162_1","TANKYRASE-2","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",7,"HIS A 415;GLY A 416;TYR A 449;ALA A 451;SER A 457;TYR A 460;GLU A 545","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 ( 4.1A);UHB A1001 (-2.5A);UHB A1001 (-3.4A);UHB A1001 (-3.5A)","0.78A","4bjcA-5dsyA:18.4","4bjcA-5dsyA:29.11"],["4HYF_A_NCAA1201_0","TANKYRASE-2","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",7,"HIS A 415;GLY A 416;TYR A 449;ALA A 451;SER A 457;TYR A 460;GLU A 545","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 ( 4.1A);UHB A1001 (-2.5A);UHB A1001 (-3.4A);UHB A1001 (-3.5A)","0.61A","4hyfA-5dsyA:19.5","4bjcA-5dsyA:29.11"],["4HYF_B_NCAB1201_0","TANKYRASE-2","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",8,"HIS A 415;GLY A 416;TYR A 449;ALA A 451;LYS A 456;SER A 457;TYR A 460;GLU A 545","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 ( 4.1A);UHB A1001 ( 4.6A);UHB A1001 (-2.5A);UHB A1001 (-3.4A);UHB A1001 (-3.5A)","0.93A","4hyfB-5dsyA:19.7","4hyfA-5dsyA:29.11"],["4HYF_C_NCAC1201_0","TANKYRASE-2","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",8,"HIS A 415;GLY A 416;TYR A 449;ALA A 451;LYS A 456;SER A 457;TYR A 460;GLU A 545","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 (-3.8A);UHB A1001 ( 4.1A);UHB A1001 ( 4.6A);UHB A1001 (-2.5A);UHB A1001 (-3.4A);UHB A1001 (-3.5A)","0.57A","4hyfC-5dsyA:19.6","4hyfB-5dsyA:29.11"],["4J26_A_ESTA600_1","ESTROGEN RECEPTOR BETA","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",5,"LEU A 471;MET A 556;LEU A 356;GLY A 429;LEU A 430","None;None;None;None;UHB A1001 ( 4.7A)","1.29A","4j26A-5dsyA:undetectable","4hyfC-5dsyA:29.11"],["4RV6_A_RPBA1103_1","POLY [ADP-RIBOSE] POLYMERASE 1","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",9,"HIS A 415;GLY A 416;TYR A 442;TYR A 449;ALA A 451;LYS A 456;SER A 457;TYR A 460;GLU A 545","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 ( 4.7A);UHB A1001 (-3.8A);UHB A1001 ( 4.1A);UHB A1001 ( 4.6A);UHB A1001 (-2.5A);UHB A1001 (-3.4A);UHB A1001 (-3.5A)","0.57A","4rv6A-5dsyA:35.2","4j26A-5dsyA:23.33"],["4RV6_B_RPBB1103_1","POLY [ADP-RIBOSE] POLYMERASE 1","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",9,"HIS A 415;GLY A 416;TYR A 442;TYR A 449;ALA A 451;LYS A 456;SER A 457;TYR A 460;GLU A 545","UHB A1001 (-3.7A);UHB A1001 (-3.9A);UHB A1001 ( 4.7A);UHB A1001 (-3.8A);UHB A1001 ( 4.1A);UHB A1001 ( 4.6A);UHB A1001 (-2.5A);UHB A1001 (-3.4A);UHB A1001 (-3.5A)","0.57A","4rv6B-5dsyA:36.1","4rv6A-5dsyA:40.17"],["5HA9_B_TP0B406_1","POLY [ADP-RIBOSE] POLYMERASE 1","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",7,"HIS A 415;SER A 417;ASN A 421;ILE A 425;TYR A 449;SER A 457;TYR A 460","UHB A1001 (-3.7A);UHB A1001 (-2.5A);UHB A1001 (-3.7A);UHB A1001 (-4.6A);UHB A1001 (-3.8A);UHB A1001 (-2.5A);UHB A1001 (-3.4A)","0.53A","5ha9B-5dsyA:32.8","4rv6B-5dsyA:40.17"],["5Y2T_A_8LXA501_0","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","5dsy","POLY [ADP-RIBOSE] POLYMERASE 2","Homo sapiens",5,"PHE A 444;GLY A 445;TYR A 460;ILE A 432;LEU A 541","None;None;UHB A1001 (-3.4A);None;None","1.01A","5y2tA-5dsyA:undetectable","5ha9B-5dsyA:40.17"]]